Welcome to LookChem.com Sign In|Join Free

CAS

  • or

29476-22-0

Post Buying Request

29476-22-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

29476-22-0 Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule of the compound.

Explanation

A heterocyclic compound is a cyclic compound containing atoms of at least two different elements, in this case, carbon, nitrogen, oxygen, and sulfur.

Explanation

The compound has a fused benzene (C6H6) and thiazepine (a seven-membered ring with one sulfur and one nitrogen atom) ring structure.

Explanation

The compound has been studied for its potential use in the development of therapeutic drugs, indicating it may have pharmacological properties.

Explanation

The compound may have applications in the field of medicinal chemistry, particularly in the development of drugs for the treatment of various diseases and conditions.

Explanation

More research and studies are required to fully understand the properties and potential uses of this chemical compound, as its pharmacological properties and applications are still under investigation.

Heterocyclic Compound

Yes

Contains Benzene and Thiazepine Rings

Yes

Potential Pharmacological Properties

Yes

Applications

Medicinal Chemistry

Further Research Needed

Yes

Check Digit Verification of cas no

The CAS Registry Mumber 29476-22-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,4,7 and 6 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 29476-22:
(7*2)+(6*9)+(5*4)+(4*7)+(3*6)+(2*2)+(1*2)=140
140 % 10 = 0
So 29476-22-0 is a valid CAS Registry Number.

29476-22-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Phenyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one

1.2 Other means of identification

Product number -
Other names 2,3-dihydro-2-phenyl-1,5-benzothiazepin-4-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:29476-22-0 SDS

29476-22-0Relevant articles and documents

Discovery of Novel Benzothiazepinones as Irreversible Covalent Glycogen Synthase Kinase 3β Inhibitors for the Treatment of Acute Promyelocytic Leukemia

Zhang, Peng,Min, Zhihui,Gao, Yang,Bian, Jiang,Lin, Xin,He, Jie,Ye, Deyong,Li, Yilin,Peng, Chao,Cheng, Yunfeng,Chu, Yong

, p. 7341 - 7358 (2021/06/28)

Recently, irreversible inhibitors have attracted great interest in antitumors due to their advantages of forming covalent bonds to target proteins. Herein, some benzothiazepinone compounds (BTZs) have been designed and synthesized as novel covalent GSK-3β inhibitors with high selectivity for the kinase panel. The irreversible covalent binding mode was identified by kinetics and mass spectrometry, and the main labeled residue was confirmed to be the unique Cys14 that exists only in GSK-3β. The candidate 4-3 (IC50 = 6.6 μM) showed good proliferation inhibition and apoptosis-inducing ability to leukemia cell lines, low cytotoxicity on normal cell lines, and no hERG inhibition, which hinted the potential efficacy and safety. Furthermore, 4-3 exhibited decent pharmacokinetic properties in vivo and remarkably inhibited tumor growth in the acute promyelocytic leukemia (APL) mouse model. All the results suggest that these newly irreversible BTZ compounds might be useful in the treatment of cancer such as APL.

Efficient synthesis of 1,4-thiazepanones and 1,4-thiazepanes as 3d fragments for screening libraries

Pandey, Anil K.,Kirberger, Steven E.,Johnson, Jorden A.,Kimbrough, Jennifer R.,Partridge, Danika K. D.,Pomerantz, William C. K.

supporting information, p. 3946 - 3950 (2020/06/08)

1,4-Thiazepanes and 1,4-thiazepanones represent seven-membered ring systems with highly 3D character and are currently underrepresented in fragment screening libraries. A nuclear magnetic resonance (NMR) fragment screen identified 1,4-acylthiazepanes as new BET (bromodomain and extraterminal domain) bromodomain ligands; however, an efficient and readily diversified synthesis for library development has not been reported. Here we report a one-pot synthesis using α,β-unsaturated esters and 1,2-amino thiols to form 1,4-thiazepanones as precursors to 1,4-thiazepanes with high 3D character. This reaction proceeds in reasonable time (0.5-3 h) and in good yield and tolerates a broad scope of α,β-unsaturated esters. Several 1,4-thiazepanes were synthesized by a two-step transformation and were characterized as new BET bromodomain ligands using protein-observed 19F NMR. This synthesis should provide ready access to diverse 3D fragments for screening libraries.

Catalytic Enantioselective Synthesis of Protecting-Group-Free 1,5-Benzothiazepines

Meninno, Sara,Volpe, Chiara,Lattanzi, Alessandra

supporting information, p. 4547 - 4550 (2017/04/13)

A one-pot enantioselective route to N-unprotected 2,3-dihydro-1,5-benzothiazepinones, by an organocatalyzed sulfa-Michael reaction of readily available α,β-unsaturated N-acyl pyrazoles with 2-aminothiophenols followed by silica-gel-catalyzed lactamization

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 29476-22-0